More than 53,000 managed care clients in 6 western New York counties will not have to find a new insurer, thanks to an emerging partnership that caused the area's BlueCross BlueShield carrier to reverse its decision to exit the health plans.
More than 53,000 managed care clients in 6 western New York counties will not have to find a new insurer, thanks to an emerging partnership that caused the area’s BlueCross BlueShield carrier to reverse its decision to exit the health plans.
In a statement yesterday, BlueCross BlueShield (BCBS) of Western New York announced that policyholders in Eric, Cattaraugus, Chautauqua, Orleans, Wyoming, and Allegany counties will be able to keep Medicaid and Child Health plus plans, which BCBS spokeswoman Julie R. Snyder called a “difficult decision” that came “in spite of significant efforts to address chronic underfunding of these programs by New York state.”
In July 2014, BCBS of Western New York gave notice to state health department regulators that it was pulling out of managed care in the 6 counties, a move that would have been effective October 31, 2014. However, according to Snyder’s statement and a report in The Buffalo News, a potential partner came forward and offered to help run the plans with the Blues.
BCBS, which is the fourth-largest provider of Medicaid and Child Plus managed care in the affected counties, had previously canceled its Medicaid managed care program in Niagara and Genesee counties. The company cited losses of $40 million over the past 3 years in announcing its withdrawal in July.
News of the reversal was not a surprise, since BCBS had not sent out notices of cancellation 60 days prior to the projected October 31 cancellation date, which are required by law.
Difficulties with Medicaid managed care are not limited to New York state. Several states have reported problems with transitions to managed care, including slow payments to providers. Insurers in Kansas who contracted to run a new Medicaid managed care program have reported steep losses, prompting calls for an investigation. Yet, a recent survey by the Kaiser Family Foundation found many states still plan to try to expand managed care in Medicaid in 2015, in search of savings for state budgets.
The move by BCBS of Western New York means that the insurer has given formal notice to regulators of plans to suspend its withdrawal from the state-sponsored programs while it continues discussions with the unnamed strategic partner.
“BlueCross BlueShield of Western New York has a 78-year history in the region and remains committed to providing all our state sponsored members access to the highest quality health care by joining with a recognized industry partner,” Snyder said, without naming the partner.
Around the Web
BlueCross BlueShield Reverses its Decision to Exit Medicaird and Child Health Plus
Critics of Kansas Medicaid Privatization Program Call for Investigation
Medicaid in an Era of Health Delivery System Reform: Results from a 50-State Medicaid Budget Survey
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More